Literature DB >> 26750601

Dual Function of DNA Sequences: Protein-Coding Sequences Function as Transcriptional Enhancers.

Naama Hirsch, Ramon Y Birnbaum.   

Abstract

Most of our genome comprises noncoding sequences that include diverse transcriptional regulatory elements, such as enhancers, while only ~1.5% of the genome codes for proteins. Nevertheless, DNA sequences that code for protein (exons) can also function as enhancers (eExons) that regulate transcription. Mutations in eExons can lead to multiple phenotypes due to their dual function. The prevalence of protein-coding sequences that possess transcriptional regulatory function (such as eExons) and the consequences of their mutations are not well described. Using advanced sequencing technologies, protein-coding sequences were analyzed for their potential regulatory function in mammalian cells and found to be overrepresented in the genome (>6%). Dissection of the enhancer activity of eExons at single nucleotide resolution in liver cells has demonstrated that: (1) most nucleotide changes with high impact effect are deleterious; (2) deleterious enhancer mutations are correlated with the location of transcription factor-binding sites; (3) synonymous and non-synonymous mutations have similar effects on enhancer activity; and (4) the transcription factor repertoire that controls the activity of enhancers differs across cell types, indicating differences in deleterious mutation profiles. Thus, eExon mutations can disrupt both protein structure and enhancer activity with differential effect across cell types, suggesting that a mutation in a gene could cause a phenotype that has nothing to do with its protein-coding function but is due to its additional hidden regulatory function.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26750601     DOI: 10.1353/pbm.2015.0026

Source DB:  PubMed          Journal:  Perspect Biol Med        ISSN: 0031-5982            Impact factor:   1.416


  4 in total

1.  A map of cis-regulatory modules and constituent transcription factor binding sites in 80% of the mouse genome.

Authors:  Pengyu Ni; David Wilson; Zhengchang Su
Journal:  BMC Genomics       Date:  2022-10-19       Impact factor: 4.547

2.  HDAC9 structural variants disrupting TWIST1 transcriptional regulation lead to craniofacial and limb malformations.

Authors:  Naama Hirsch; Idit Dahan; Eva D'haene; Matan Avni; Sarah Vergult; Marta Vidal-García; Pamela Magini; Claudio Graziano; Giulia Severi; Elena Bonora; Anna Maria Nardone; Francesco Brancati; Alberto Fernández-Jaén; Olson J Rory; Benedikt Hallgrímsson; Ramon Y Birnbaum
Journal:  Genome Res       Date:  2022-06-16       Impact factor: 9.438

3.  Activating transcription factor 4 (ATF4) promotes skeletal muscle atrophy by forming a heterodimer with the transcriptional regulator C/EBPβ.

Authors:  Scott M Ebert; Steven A Bullard; Nathan Basisty; George R Marcotte; Zachary P Skopec; Jason M Dierdorff; Asma Al-Zougbi; Kristin C Tomcheck; Austin D DeLau; Jacob A Rathmacher; Sue C Bodine; Birgit Schilling; Christopher M Adams
Journal:  J Biol Chem       Date:  2020-01-17       Impact factor: 5.157

4.  RefSeq Functional Elements as experimentally assayed nongenic reference standards and functional interactions in human and mouse.

Authors:  Catherine M Farrell; Tamara Goldfarb; Sanjida H Rangwala; Alexander Astashyn; Olga D Ermolaeva; Vichet Hem; Kenneth S Katz; Vamsi K Kodali; Frank Ludwig; Craig L Wallin; Kim D Pruitt; Terence D Murphy
Journal:  Genome Res       Date:  2021-12-07       Impact factor: 9.438

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.